Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain
NCT01028352
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Duloxetine
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
[object Object]